欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-CD29 mAbs

简要描述:

This antibody recognises a ligand-induced binding site on the βA domain of β1 integrin, and thus reacts preferentially with α5β1 integrins in the ligand-activated state. Binding of this antibody alters the position of the α1 helix of β1 integrin, and results in further integrin activation.

产品参数:

Cat. No.:MABL-862

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:enhance, therapeutic, WB, ELISA, FC, IHC

详细介绍

Key features and details


Cat. No.

MABL-862

Name

Anti-CD29 mAbs

Clone No.

AFD- 12G10

From

Recombinant Antibody

Isotype

Engineer antibody

Application

enhance, therapeutic, WB, ELISA, FC, IHC

Species Reactivity

Human

Basic Information


Specificity

This antibody recognises a ligand-induced   binding site on the βA domain of β1 integrin, and thus reacts preferentially   with α5β1 integrins in the ligand-activated state. Binding of this antibody   alters the position of the α1 helix of β1 integrin, and results in further   integrin activation.

Alternative Name

Integrin beta-1; Integrin β1 chain; Integrin   β1; VLA-β chain; Glycoprotein Iia; GPIIA; Fibronectin receptor subunit beta;  ITGB1; VLA-4 subunit beta; FNRB; MDF2; MSK12

UniProt

P05556

Immunogen

This antibody was raised by immunising BALB/C   mice with purified β1 integrins from HT-1080 fibrosarcoma cells

Application Notes

This antibody reacts with β1 integrins in   Western blotting (Mould et al, 1995). ELISA analysis has revealed the ability   of this antibody to enhance the interaction between β1 integrin and its   ligand, fibronectin (Mould et al, 1995). Indeed, activation of integrins by   this antibody reduced the induction of osteosarcoma growth and inhibition of   NF-κB caused by hERG1 knockdown in osteosarcoma cells (Zeng et al, 2016).   This antibody has been used to specifically label ligand-bound cell surface   β1 integrins both in immunohistochemical analysis (Izumi et al, 2015; Chao   & Kunz, 2009), including in situ proximity ligation (PLA) analysis (Nevo   et al, 2010), and in FACS analysis (Brandt et al, 2009).

Antibody First Published

Mould et al. Identification of a novel   anti-integrin monoclonal antibody that recognises a ligand-induced binding   site epitope on the beta 1 subunit. FEBS Lett. 1995 Apr 17;363(1- 2):118-22.   PMID:7537221

Note on publication

Describes the original generation of this   antibody, and its characterisation through Western blotting and ELISA   experiments.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity purified

Buffer

PBS with 0.02% Proclin 300.

Concentration

1 mg/ml.

Storage Recommendation

Store at 4⁰C for up to 3 months. For   longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-CD28 mAbs

下一篇: Anti-CD29 mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号